Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
NewGenIvf Group Limited

NewGenIvf Group Limited (NIVF) Stock Overview

Explore NewGenIvf Group Limited’s financial performance, market position, analyst ratings, and future outlook.

NIVF●NASDAQ
HealthcareMedical - Care Facilities
$0.85
$0.08(8.18%)
U.S. Market opens in 10h 14m

NewGenIvf Group Limited (NIVF)

Meyka AI Score

Z

Key Financials

Market Cap159.8K
P/E Ratio0.02
EPS (TTM)$2.03
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$2.91
3 Months$1.41
1 Year Target$0.37

NIVF Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of NewGenIvf Group Limited (NASDAQ: NIVF) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, NewGenIvf Group Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NIVF on the NASDAQ shows an RSI of 38.09, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.37 for the NASDAQ listing.

Key metrics behind NewGenIvf Group Limited's NASDAQ-traded stock include a P/E ratio of 0.02 and a market capitalization of 159.8K. Combined with our AI analysis, these give both institutional and retail investors a clear view of NIVF on the NASDAQ.

Price Performance (NASDAQ: NIVF)

1-Day Change
-9.32%
5-Day Change
-29.13%
1-Month Change
-45.94%
3-Month Change
-84.64%
6-Month Change
-94.76%
Year-to-Date (YTD) Change
-96.61%
1-Year Change
-99.80%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.nivf.global
66 2 116 9641
PS Tower, 36/39-36/40, 13th Floor, Bangkok, BM, 10110

Company Facts

870 Employees
IPO DateMar 18, 2022
CountryTH
Actively Trading

Frequently Asked Questions